ĀÜĄņĀŅĀ×

Joe Salas brings to Ensoma an extensive track record discovering and advancing drug candidates into clinical development. Most recently, he served as the head of hemophilia and musculoskeletal disorders in Sanofiā€™s Rare Disease Unit, where he managed a diverse portfolio of novel therapeutics to address bleeding disorders and muscular dystrophies.